Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Jupiter Bioscience Of India Seeks U.S., Europe Acquisitions

This article was originally published in PharmAsia News

Executive Summary

India's Jupiter Bioscience says it is discussing with several companies as possible acquisition targets to build its strength in the United States and Europe. The firm plans to spend about $15 million through the coming year to acquire a company in each of the two markets. Jupiter Chairman Venkat Kalavakolanu did not name firms it was talking to, but said some are high-end research companies specializing in peptides and others specialize in building-blocks. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts